Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Treasury Shares (2019 - 2022)

Cue Biopharma's Treasury Shares history spans 4 years, with the latest figure at $6667.0 for Q2 2022.

  • For Q2 2022, Treasury Shares fell 96.87% year-over-year to $6667.0; the TTM value through Jun 2022 reached $6667.0, down 96.87%, while the annual FY2021 figure was $98335.0, 57.25% down from the prior year.
  • Treasury Shares for Q2 2022 was $6667.0 at Cue Biopharma, roughly flat from $6667.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $263335.0 in Q3 2020 and bottomed at $6667.0 in Q1 2022.
  • The 4-year median for Treasury Shares is $140834.5 (2020), against an average of $141334.7.
  • The largest annual shift saw Treasury Shares skyrocketed 130.0% in 2020 before it tumbled 96.87% in 2022.
  • A 4-year view of Treasury Shares shows it stood at $100000.0 in 2019, then surged by 130.0% to $230002.0 in 2020, then crashed by 57.25% to $98335.0 in 2021, then tumbled by 93.22% to $6667.0 in 2022.
  • Per Business Quant, the three most recent readings for CUE's Treasury Shares are $6667.0 (Q2 2022), $6667.0 (Q1 2022), and $98335.0 (Q4 2021).